<DOC>
	<DOCNO>NCT00381381</DOCNO>
	<brief_summary>This study attempt differentiate clinical response Choline Acetyltransferase Apolipoprotein Epsilon gene polymorphism donepezil Alzheimer 's Disease patient .</brief_summary>
	<brief_title>The Clinical Response Choline Acetyltransferase Apolipoprotein Epsilon Gene Polymorphisms Donepezil Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criterion : 1 . Age : 60 90 year old . 2 . CDR : 0.5 2.0 . 3 . Patients severe depressive symptom affect cognition depression scale CERADK ( C ) , GDSK : 19 . 4 . Modified Hachinski Ischemic Score ( Rosen , et . al. , 1979 ) : 3 . 5 . NINCDSADRDA criterion : Probable AD . Exclusion criterion : 1 . Patients delusion conscious dysfunction . 2 . Patients neurologic disease Parkinson 's disease , stroke , tumor , normal pressure hydrocephalus , etc. , history neurologic examination . 3 . Patients history infectious inflammatory brain disease owe virus , fungus syphilis . 4 . Patients severe cerebrovascular pathology . 5 . Patients present history major psychological disease depression mania accord DSMIV criterion . 6 . Patients history alcoholism drug addiction . 7 . Patients severe depressive symptom affect cognition depression scale CERADK .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Alzheimer 's disease</keyword>
</DOC>